| Acquirer | Target | Price |
|---|---|---|
| Johnson & Johnson | Actelion Ltd. | $30.1 billion |
| McKesson Corporation | CoverMyMeds | $1.4 billion |
| Celgene Corporation | Delinia, Inc. | $300 million |
| Generex Biotechnology Corp. | Emmaus Life Sciences, Inc. | $225 million |
| Intrexon Corporation | GenVec Inc. | $15.9 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
